Disturbances in some gene expression in T regulatory cells separated from children with metabolic syndrome

Scandinavian Journal of Immunology

Volumn 71, Issue 2, 2010, Pages 115-122

  Luczynski W ^a   Stasiak Barmuta, A ^a   Wawrusiewicz Kurylonek, N ^a   Kowalczuk, O ^a   Ilendo E ^a   Glowinska Olszewska B ^a   Urban, R ^a   Szczepanski W ^a   Urban, M ^a   Krtowski A ^a   Chyczewski, L ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EBI3 PROTEIN; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; ICOS 1 PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 7 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; PRF 1 PROTEIN; PROTEIN; SMAD3 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL SEPARATION; CHILD; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; METABOLIC SYNDROME X; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 75149175190     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02354.x     Document Type: Article

References (54)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37: 1595 1607.
2. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006 83: 1237 1247.
3. Zimmet P, Alberti KG, Kaufman F et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007 8: 299 306.
4. Blüher M. The inflammatory process of adipose tissue. Pediatr Endocrinol Rev 2008 6: 24 31.
5. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med (Maywood) 2002 227: 989 997.
6. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008 79: 360 376.
7. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006 26: 2421 2432.
8. Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27: 2493 2495.
9. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 155: 1151 1164.
10. Nizar S, Copier J, Meyer B et al. T-regulatory cell modulation: the future of cancer immunotherapy? Br J Cancer 2009 100: 1697 1703.
11. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008 8: 523 532.
12. + T cells. Cell Mol Immunol 2006 3: 189 195.
13. Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450: 566 569.
14. Svec P, Vásárhelyi B, Pászthy B et al. Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 2007 115: 439 443.
15. -ddCT method. Methods 2001 25: 402 408.
16. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004 350: 2362 2374.
17. + regulatory T cells. Nat Immunol 2003 4: 330 336.
18. + T regulatory cells. Nat Immunol 2003 4: 337 342.
19. + T reg cells. J Exp Med 2006 203: 1701 1711.
20. Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006 203: 1693 1700.
21. Torcia MG, Santarlasci V, Cosmi L et al. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. PNAS 2008 105: 646 651.
22. Kim DJ, Noh JH, Lee BW et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci 2008 23: 193 198.
23. Tanigawa T, Iso H, Yamagishi K et al. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. Atherosclerosis 2004 173: 295 300.
24. Collison LW, Pillai MR, Chaturvedi V, Vignali DA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35 and IL-10-dependent manner. J Immunol 2009 182: 6121 6128.
25. Kryczek I, Liu R, Wang G et al. FoxP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 2009 69: 3995 4000.
26. Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev 2008 226: 248 262.
27. + regulatory T cells. J Immunol 2008 181: 3870 3876.
28. + regulatory T cells do not constitutively express IL-35. J Immunol 2008 181: 6898 6905.
29. Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev 2008 226: 234 247.
30. Huber M, Steinwald V, Guralnik A et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol 2008 20: 223 234.
31. + regulatory T cell activity in both humans and mice. J Immunol 2004 172: 834 842.
32. Gregg RK, Jain R, Schoenleber SJ et al. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol 2004 173: 7308 7316.
33. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005 35: 2886 2895.
34. Wood KJ, Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006 27: 183 187.
35. + blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl Int 2008 21: 646 660.
36. Schmidt EM, Wang CJ, Ryan GA et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J Immunol 2009 182: 274 282.
37. Gotsman I, Grabie N, Gupta R et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006 114: 2047 2055.
38. + T cells. J Immunol 2007 179: 1427 1430.
39. high regulatory T cells in peripheral blood of patients with multiple sclerosis. Clin Exp Immunol 2008 154: 22 9.
40. So T, Lee SW, Croft M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev 2008 19: 253 262.
41. Luczynski W, Wawrusiewicz-Kurylonek N, Stasiak-Barmuta A et al. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. Acta Biochim Pol 2009 56: 361 370.
42. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005 174: 1783 1786.
43. Grossman WJ, Verbsky JW, Barchet W, Colonna MM, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 21: 589 601.
44. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004 104: 2840 2848.
45. + natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 2006 18: 1197 1209.
46. Muthukumarana P, Chae WJ, Maher S, Rosengard BR, Bothwell AL, Metcalfe SM. Regulatory transplantation tolerance and "stemness": evidence that FoxP3 may play a regulatory role in SOCS-3 gene transcription. Transplantation 2007 84 (1 Suppl. s6 11.
47. Tsao JT, Kuo CC, Lin SC. The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Clin Exp Med 2008 8: 179 185.
48. Isomäki P, Alanärä T, Isohanni P et al. The expression of SOCS is altered in rheumatoid arthritis. Rheumatology (Oxford) 2007 46: 1538 1546.
49. 1 cytokines: the role of IL-27-induced STAT1. J Immunol 2009 182: 1041 1049.
50. 1 cells. J Immunol 2009 183: 797 801.
51. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008 263: 489 499.
52. Taleb S, Herbin O, Ait-Oufella H et al. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27: 2691 2698.
53. Kuiper J, van Puijvelde GH, van Wanrooij EJ et al. Immunomodulation of the inflammatory response in atherosclerosis. Curr Opin Lipidol 2007 18: 521 526.
54. Mallat Z, Gojova A, Brun V et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108: 1232 1237.